Integrated Genomics (Chicago) is Under New Ownership (12/7/2010)

Integrated Genomics develops products for research in microbial genomics, biochemistry and gene expression. Among the company’s co-founders is Dr. Robert Haselkorn, who is the F.L. Pritzker Distinguished Service Professor at the University of Chicago.

From the company’s press release:
Integrated Genomics™ is under new ownership. Integrated Genomics, Inc. became insolvent and all of its assets were siezed by its creditors. IG Assets, Inc., an Illinois corporation, acquired the rights to the Integrated Genomics™ brand and its intellectual property in December of 2010. IG Assets, Inc., now operates the Integrated Genomics™ brand and continues to provide ERGO™ subscriptions and genome analysis services. IG Assets, Inc., has not assumed any of the obligations of Integrated Genomics, Inc. read full press release

Chromatin, Inc. (Chicago) and Syngenta Biotechnology, Inc. Collaborate to Develop Gene Stacking Technology for Soybean (9/16/2010)

Chromatin is a University of Chicago spinoff that develops and markets technologies and products that benefit the agricultural, energy, chemical, nutritional, and pharmaceutical sectors.

Chromatin, Inc. announced today an extension of its research and commercial license agreement with Syngenta Biotechnology, Inc. for corn and soybeans for Chromatin’s proprietary gene stacking technology.

The agreement furthers a three-year relationship between the two companies. Under a 2007 agreement, Syngenta obtained non-exclusive rights to use Chromatin’s gene stacking technology for trait genes in corn and soybeans, and in 2009, Syngenta obtained exclusive worldwide research and commercial license rights to that technology for use in sugar cane. Today, Chromatin announces that they have launched activities to further develop gene stacking technology for soybean applications. [read more]